A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma
Clinical trial NCT02831686 · COMPLETED
Trial details
- NCT number
- NCT02831686
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2020-11-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.